(Q42993259)

12 November 2017

Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels (English)

1 reference

12 November 2017

Puoti C

1

1 reference

PubMed ID

10220739

12 November 2017

Stati T

series ordinal

2

1 reference

PubMed ID

10220739

12 November 2017

Magrini A

series ordinal

3

1 reference

12 November 2017

1 April 1999

1 reference

12 November 2017

1 reference

12 November 2017

19

1 reference

12 November 2017

104-109

1 reference

12 November 2017

2

1 reference

Therapy of hepatitis C: patients with normal aminotransferase levels

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Interferon for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Asymptomatic infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Asymptomatic hepatitis C infection. Be cautious with liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

The role of liver biopsy in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

HCV viraemia and liver injury in symptom-free blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Infection of peripheral mononuclear blood cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Detection and quantification of hepatitis C virus RNA replication in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Should we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

Eosinophilia-myalgia syndrome, L-tryptophan, and informed consent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.1999.TB00018.X

10.1111/J.1478-3231.1999.TB00018.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

10220739